IFB-088

· InFlectis BioScience

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IFB-088, covering 2022-01-26 to 2025-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol) [Phase 2]